Status:
COMPLETED
Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients
Lead Sponsor:
Novartis
Conditions:
Kidney Transplant
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the impact of tacrolimus and cyclosporine microemulsion on glucose metabolism in kidney transplant recipients and the efficacy and safety in preventing organ r...
Eligibility Criteria
Inclusion
- \- First or second transplant, cadaveric or living donor
Exclusion
- Multi-organ or dual kidney transplants
- Panel reactive antibodies \>50%
- Other protocol-defined inclusion/exclusion criteria applied
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2006
Estimated Enrollment :
693 Patients enrolled
Trial Details
Trial ID
NCT00171496
Start Date
October 1 2003
End Date
March 1 2006
Last Update
November 18 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.